Cipla announced that the United States Food and Drug Administration (USFDA) conducted a cGMP inspection at its API manufacturing facility in Bommasandra, Bangalore from 20 January, 2020 to 24 January, 2020.

The inspection ended with 4 observations which were procedural in nature and none of which were repeat or related to data integrity. The Company is committed to address these observations and will submit its response to the USFDA within the stipulated time

The Board of CG Power & Industrial Solutions at its meeting held on 24 January 2020 has appointed Dr Rathin Roy (DIN: 008662401) and Dr Aditi Raja (DIN: 00164313) as Additional and Non Executive Independent Directors of the Company with effect from 24 January 2020.

EID Parry (India) has allotted 1000 Rated, Listed, Secured, Redeemable Non-Convertible Debentures of face value of Rs.10,00,000 each aggregating to Rs. 100 crore on 24 January 2020.

Graviss Hospitality will hold a meeting of the Board of Directors of the Company on 31 January 2020.

Grindwell Norton will hold a meeting of the Board of Directors of the Company on 4 February 2020.